Help us change lives
At Exact Sciences were helpingchange how the world prevents detects and guides treatment for cancer. We give patients and clinicians the clarity needed to make confident decisions when they matter most. Join our team to find a purpose-driven career an inclusive culture and robust benefits to support your life while youre working to help others.
COMPANY OVERVIEW
Exact Sciences is dedicated to delivering patient critical answers across the cancer journey from early detection to treatment decision making with a strong focus on people and an empathetic spirit which fuels the companys culture driving them to create and deliver solutions rooted in the needs of patients providers and families. From earlier cancer detection to treatment guidance and monitoring Exact Sciences are helping people get the answers they need to make more informed decisions across the cancer continuum. With a leading portfolio of products for earlier detection and treatment guidance they help people face the most challenging decisions with confidence with a dedication to continuously innovate combining scientific rigor with an open-minded approach to deliver the next big thing.
Exact Sciences is continuously expanding the pipeline with the aim of tackling a wider array of cancer tests through the following measures:
By 2020 Oncotype DX will have been used to guide treatment decisions for more than 1 million cancer patients worldwide in breast prostate and colon cancer.
In July 2019 Exact Sciences acquired Genomic Health a genetic cancer detection company based in Redwood City California for USD 2.8 billion creating the leading global cancer diagnostics company.
In 2020 Exact Sciences acquired Thrive Earlier Detection Corp. a Massachusetts-based healthcare company in a multi-billion-dollar deal and Base Genomics which has technology for DNA methylation analysis.
In February 2021 Exact Sciences announced the acquisition of Ashion Analytics LLC (Ashion) from The Translational Genomics Research Institute (TGen) an affiliate of City of Hope. Ashion is a CLIA-certified and CAP-accredited sequencing lab based in Phoenix Arizona with the genomics testing capabilities necessary to address the increasingly complex needs of clinical academic and biopharma customers focused on precision cancer treatments.
The company is based in the United States with international headquarters in Zug Switzerland.
POSITION SUMMARY
The International Medical Director Screening Portfolio at Exact Sciences manages research and educational medical objectives while supporting international commercial business and reimbursement objectives for novel assays which lead to improved treatment decisions. The position will be responsible for driving International medical & developmental strategy for new technologies in Screening. The International region includes Europe Canada Africa Asia Pacific Latin America.
Key responsibilities include creating clinical studies strategy building international medical plans engagement of selected key opinion leaders planning of international advisory boards developing international medical education programs maintaining product/therapeutic area expertise and delivering presentations and training internally.
RESPONSIBILITIES / DUTIES:
Pivotal Experience & Expertise
Cultural Impact
Other
Our success relies on the experiences and perspectives of a diverse team and Exact Sciences fosters a culture where all employees can develop personally and professionally with a sense of respect and belonging. If you require an accommodation please contact us here.
Not ready to apply Join our Talent Community to stay updated on the latest news and opportunities at Exact Sciences.
Required Experience:
Staff IC
Exact Sciences’ products, services, mission, and people all work together to support early cancer detection and smarter treatment decisions.